Compare Berkshire Hathaway Inc Class B (BRK.B) vs Moderna, Inc. (MRNA) Price & Performance

Berkshire Hathaway Inc Class BTrade

Moderna, Inc.Trade

Price performance (Past 24H)

Key statistics

Berkshire Hathaway Inc Class B vs Moderna, Inc. — how do they compare? Berkshire Hathaway Inc Class B trades at $489.83, while Moderna, Inc. trades at $67.91 (market cap $26.76B). The key difference: Moderna, Inc. is trading nearer its 52-week high, Berkshire Hathaway Inc Class B nearer its low. Which is the better fit depends on your goals.

	BRK.B	MRNA
Sector	Financials	Health
52-Week High	$513.70	$81.80
52-Week Low	$459.10	$22.36
Market Cap	—	$26.76B
Enterprise Value	—	$22.85B

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Berkshire Hathaway Inc Class B

No Aura AI signal available yet.

Moderna, Inc.

Moderna (MRNA) trades at $67.01, down 1.85% today, with a bullish technical signal from moving averages. The company continues to post net losses despite beating EPS estimates in recent quarters, with revenue declining from pandemic peaks. Recent news highlights pipeline expansion into oncology and autoimmune diseases, with an FDA decision on its mRNA flu vaccine expected by August 5, 2026.

While Moderna's pipeline diversification offers long-term growth potential, significant risks remain from persistent negative profitability and high valuation multiples. Analyst consensus is cautious with a $49 price target below current levels, suggesting limited near-term upside despite recent positive developments in vaccine approvals and strategic shifts.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BRK.B

Warren Buffett redirects charitable donations from Gates Foundation to his family foundations.CNBC · 6 hours agoNeutral Warren Buffett plans to donate all Berkshire shares within 8 years, excluding Gates Foundation.CNBC · 1 day agoNeutral Buffett redirects $9M Berkshire shares donation from Gates Foundation to family-linked foundations.CNBC · 1 day agoNeutral View details →

MRNA

Moderna's Q2 report expected uneventful; key focus on COVID vaccine demand and Phase III melanoma data.Proactive Investors · 1 day agoNeutral View details →

About Berkshire Hathaway Inc Class B

Berkshire Hathaway is a holding company with diverse subsidiaries, primarily in insurance through Geico and its reinsurance groups. It reinvests profits into various industries, owning Burlington Northern Santa Fe (railroad), Berkshire Hathaway Energy, and major manufacturing, service, and retail businesses like Precision Castparts and Lubrizol. The company operates in a highly decentralized manner.

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.